Subject Index to Volume 36, 2023 ================================ * **Abortion,** provision, and core values of family medicine, 36(4):583–590 * **Academic detailing,** panel management, and colorectal cancer stool-DNA testing, 36(6):933–941 * **Access to health care,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Access to primary care,** integrating harm reduction into medical care, 36(3):449–461 * **Accountable care organization,** deployment of digital advance care planning platform, 36(6):966–975 * **Accreditation Council for Graduate Medical Education (ACGME)** *  implementing competency-based ABFM board eligibility, 36(4):703–707 *  new family and medical leave policy, 36(1):190–192 * **Acute pain,** initial care for low back pain, 36(6):986–995 * **Adolescent** *  failure to participate in sports, 36(6):1033–1037 *  integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Advance care planning,** deployment of digital platform, 36(6):966–975 * **Advanced practice providers,** in family medicine departments, 36(6):1058–1061 * **Adverse childhood experiences (ACEs),** parental, and child weight, 36(1):39–50 * **Adverse drug event,** ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 * **Aging** *  deployment of digital advance care planning platform, 36(6):966–975 *  peripheral neuropathy and reduced life expectancy, 36(3):431–438 * **Altruism,** an exploration of professionalism in practice, 36(3):515–519 * **American Board of Family Medicine (ABFM)** *  implementing competency-based ABFM board eligibility, 36(4):703–707 *  Introducing the Inaugural ABFM Research and Editing Fellow, 36(4):530 * **Angioedema,** of the small bowel, ACE inhibitor-induced, 36(1):160–163 * **Angiotensin-converting enzyme (ACE) inhibitors,** and angioedema of the small bowel, 36(1):160–163 * **Antibacterial drug resistance,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Antidepressants,** tapering routine, 36(1):145–151 * **Antimicrobial stewardship,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Anxiety disorders,** antidepressant tapering routine, 36(1):145–151 * **Arizona,** ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Artificial intelligence (AI),** applications in primary care, 36(2):210–220 * **Asthma** *  diagnosis documentation, childhood wheeze and, 36(6):1038–1042 *  quality of care for Latinx children with, 36(4):616–625 *  reducing carbon footprint when prescribing inhalers, 36(2):356–359 *  what patients call their inhalers, 36(4):650–661 * **Athletes,** failure of preparticipation sports physicals, 36(6):1033–1037 * **Behavioral medicine** *  clinical model of suffering, 36(2):344–355 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Behavioral science,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Bipolar disorder,** antidepressant tapering routine, 36(1):145–151 * **Bisphosphonates,** versus denosumab, for reducing fractures, 36(1):175–185 * **Body composition** *  models for delivering weight management, 36(4):603–615 *  weight loss management in primary care, 36(1):51–65 * **Body mass index,** parental ACEs and child weight, 36(1):39–50 * **Breast cancer** *  lung cancer screening among mammography patients, 36(4):557–564 *  patient confidence in screening mammography, 36(6):942–951 *  women at high risk for, 36(6):1029–1032 * **Breast density,** patient confidence in screening mammography, 36(6):942–951 * **Breastfeeding** *  detection and management of perinatal depression, 36(6):1071–1086 *  infant and maternal vitamin D supplementation, 36(1):95–104 * **Buprenorphine** *  end of the “X-waiver” program, 36(5):867–872 *  follow-up care, nurse standing orders for, 36(5):723–730 * **Burden of illness,** ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Canada** *  AI applications in primary care, 36(2):210–220 *  continuity, payment, and terms in Canadian health, 36(1):130–141 *  providers and staff perceptions of AI, 36(2):221–228 * **Cancer,** survivorship guidelines, use of, 36(5):789–802 * **Cancer screening** *  data challenges for rural colorectal cancer screening, 36(1):118–129 *  effects of multi-component intervention, 36(6):933–941 *  experiences with lung cancer screening implementation, 36(6):952–965 *  patient confidence in screening mammography, 36(6):942–951 *  women at high risk for breast cancer, 36(6):1029–1032 * **Cancer survivors,** use of cancer survivorship guidelines, 36(5):789–802 * **Cannabinoids,** integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Cannabis** *  physician perspectives on medical cannabis, 36(4):670–681 *  use for pain versus use for other reasons, 36(6):996–1007 * **Carbon dioxide,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Carbon footprint,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Cardiology** *  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476 *  clinical decision support and medication prescribing, 36(5):777–788 * **Cardiovascular diseases** *  clinical decision support and medication prescribing, 36(5):777–788 *  risk reduction of quality improvement initiative, 36(3):462–476 * **Career choice** *  practice type and scope of care, 36(1):79–87 *  reflections in family medicine, 36(5):873–875 * **Caregiver burden,** ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Caregivers** *  children's special health care needs during COVID-19, 36(5):731–738 *  home health workers' interactions for heart failure, 36(2):369–375 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 * **Case report,** ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 * **Catastrophization,** high pain catastrophizing and opioid-related awareness, 36(2):267–276 * **Cesarean section,** family physicians providing, 36(4):565–573 * **Chemoprophylaxis,** women at high risk for breast cancer, 36(6):1029–1032 * **Chief executive officers,** increasing primary care physicians in top leadership roles, 36(4):687–689 * **Child health** *  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042 *  children's special health care needs during COVID-19, 36(5):731–738 *  quality of care for Latinx children with asthma, 36(4):616–625 * **Childhood obesity,** parental ACEs and, 36(1):39–50 * **Chronic disease** *  adherence to diabetes medications during COVID-19, 36(2):289–302 *  clinical model of suffering, 36(2):344–355 *  continuity of care and hospitalization, 36(2):303–312 *  goal-oriented prevention, 36(2):333–338 *  health insurance and chronic health conditions, 36(5):839–850 *  home health workers' interactions for heart failure, 36(2):369–375 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  obesity and patient-physician relationship, 36(2):325–332 *  tool to enhance functional status assessment, 36(1):4–14 * **Chronic obstructive pulmonary disease,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Chronic pain** *  cannabis use for pain versus use for other reasons, 36(6):996–1007 *  urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **Climate change,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Clinical competence,** role of practical wisdom in primary care, 36(4):531–536 * **Clinical decision-making** *  goal-oriented prevention, 36(2):333–338 *  role of practical wisdom in primary care, 36(4):531–536 * **Clinical decision rules,** patient-reporting system for predicting influenza, 36(5):766–776 * **Clinical decision support systems,** clinical decision support and medication prescribing, 36(5):777–788 * **Clinical medicine** *  clinical model of suffering, 36(2):344–355 *  goal-oriented prevention, 36(2):333–338 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 * **Clinical pharmacy service,** home-based primary care for older adults with limited mobility, 36(4):550–556 * **Clinical trials** *  clinical decision support and medication prescribing, 36(5):777–788 *  FDA initiative for diversity in clinical trials, 36(2):366–368 *  medical-legal partnership randomized clinical trials, 36(3):414–424 * **Coccidioides,** extra-articular coccidioidomycosis in the knee, 36(2):376–379 * **Coccidioidomycosis,** extra-articular coccidioidomycosis in the knee, 36(2):376–379 * **Cohort studies,** use of patient-reporting system for predicting influenza, 36(5):766–776 * **Collaborative learning,** implementing whole person primary care, 36(4):542–549 * **Colonoscopy** *  data challenges for rural colorectal cancer screening, 36(1):118–129 *  severe harm due to screening colonoscopy, 36(3):493–500 * **Colorado,** weight loss management in primary care, 36(1):51–65 * **Colorectal cancer** *  data challenges for rural screening, 36(1):118–129 *  effects of multi-component intervention on screening, 36(6):933–941 *  guidelines for germline testing of, 36(2):360–365 *  severe harm due to screening colonoscopy, 36(3):493–500 * **Commentaries** *  The ACGME's New Paid Family and Medical Leave Policy: Just the Beginning, 36(1):190–192 *  Delivering High-Quality Primary Care Requires Work That Is Worthwhile for Medical Assistants, 36(1):193–199 *  Diversifying the Federal Family Medicine Physician Workforce, 36(1):200–202 *  The End of the X-waiver: Excitement, Apprehension, and Opportunity, 36(5):867–872 *  Ensuring Community Is at the Table in Family and Community Medicine Research: Highlighting Dr. Kevin Grumbach’s Speech as Recipient of the 2022 NAPCRG Wood Award, 36(6):1068–1070 *  The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36(2):366–368 *  Few Primary Care Physicians Lead Hospitals, Despite Their Immense Value: Systems Change and Delivery System Evolution Can Reverse This Trend, 36(4):687–689 *  Fraud, Access, and the Future of Telemedicine, 36(5):864–866 *  Medicare Advantage: Growth Amidst Mounting Scrutiny, 36(6):1062–1064 *  Pharmacy Benefit Managers in the Eye of the Storm: Growing Multipartite Scrutiny, 36(6):1065–1067 *  A Response to the Decline in Family Practitioners Performing Obstetric Care, 36(4):690–691 *  Supporting the Capture of Social Needs Through Natural Language Processing, 36(3):513–514 * **Communication** *  clinical model of suffering, 36(2):344–355 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Community-based research** *  children's special health care needs during COVID-19, 36(5):731–738 *  delays in COVID-19-related hospitalization, 36(5):832–838 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Community health centers** *  clinical decision support and medication prescribing, 36(5):777–788 *  FQHC telemedicine care redesign, 36(5):712–722 *  health insurance and chronic health conditions, 36(5):839–850 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Community medicine** *  appointment cancellations and hospital utilization, 36(2):339–343 *  failure to participate in sports, 36(6):1033–1037 *  nurse standing orders for buprenorphine follow-up care, 36(5):723–730 * **Community resources,** social isolation and a resource referral platform, 36(5):803–816 * **Competency-based education,** implementing competency-based ABFM board eligibility, 36(4):703–707 * **Comprehensive health care,** clinical model of suffering, 36(2):344–355 * **Connective tissue,** extra-articular coccidioidomycosis in the knee, 36(2):376–379 * **Continuing medical education,** standards for dermoscopy education in primary care, 36(1):25–38 * **Continuity of patient care** *  appointment cancellations and hospital utilization, 36(2):339–343 *  clinical model of suffering, 36(2):344–355 *  continuity, payment, and terms in Canadian health, 36(1):130–141 *  continuity of care and hospitalization, 36(2):303–312 *  physician continuity and cost of care, 36(6):976–985 * **Correspondence** *  approach to hair loss in hijab-wearing individuals in primary care, 36(1):186–187 *  developing and validating a novel tool to enhance functional status assessment: the Tennessee Functional Status Questionnaire (TFSQ), 36(6):1094–1095 *  estimate of severe harms due to screening colonoscopy: a systematic review, 36(6):1092–1093 *  estimating the cardiovascular disease risk reduction of quality improvement initiative in primary care: findings from EvidenceNOW, 36(6):1087–1090 *  evaluating the uptake of antiracism training, policies, and practices in departments of family medicine, 36(6):1090–1092 *  expert consensus statement on proficiency standards for dermoscopy education in primary care, 36(4):695–696 *  FDA initiative to assure racial and ethnic diversity in clinical trials, 36(6):1095–1096 *  integrating a systematic, comprehensive e-cigarette and vaping assessment tool into the electronic health record, 36(6):1096–1097 *  it’s time to retire the term “provider” from *JABFM*’s pages, 36(3):520–521 *  keeping score of the scores: additional perspectives on the decline of family medicine ITE scores, 36(5):876–877 *  local economic inequality and the primary care physician workforce in North Carolina, 36(4):697 *  prevalence of low-value prostate cancer screening in primary care clinics: a study using the National Ambulatory Medical Care Survey, 36(3):521 *  programs can improve the diversity workforce in family medicine, 36(4):695–696 * **Cost**, of care, physician continuity and, 36(6):976–985 * **COVID-19** *  acceptance of social needs navigation, 36(2):229–239 *  ACGME's new family and medical leave policy, 36(1):190–192 *  adherence to diabetes medications during, 36(2):289–302 *  appointment cancellations and hospital utilization, 36(2):339–343 *  burnout and commitment after, 36(1):105–117 *  children's special health care needs during, 36(5):731–738 *  colorectal cancer screening outreach during, 36(6):933–941 *  and community health center care delivery, 36(6):916–926 *  death, risk of, telephonic follow-up and, 36(1):164–169 *  FQHC telemedicine care redesign, 36(5):712–722 *  fraud, access, and future of telemedicine, 36(5):864–866 *  hospitalization, COVID-19-related, delays in, 36(5):832–838 *  hospitalization, health care costs following, 36(6):883–891 *  IBH adaptations during, 36(6):1023–1028 *  impact of on care coordination patients, 36(4):662–669 *  impact on family physicians, 36(6):905–915 *  intimate partner violence and telemedicine usage, 36(5):755–765 *  Medicaid expansion and practice ownership, 36(6):892–904 *  mRNA vaccination trends, 36(6):927–932 *  telehealth and policy implications for equity, 36(5):746–754 *  vaccination and financial incentives, 36(1):170–174 *  vaccine, mRNA vaccination trends, 36(6):927–932 * **Craving,** virtual music therapy for substance use disorders, 36(6):1043–1049 * **Cross-cultural comparison,** FDA initiative for diversity in clinical trials, 36(2):366–368 * **Cross-sectional studies** *  acceptance of social needs navigation, 36(2):229–239 *  continuity of care and hospitalization, 36(2):303–312 *  family physicians providing cesarean sections, 36(4):565–573 *  high pain catastrophizing and opioid-related awareness, 36(2):267–276 *  home health workers' interactions for heart failure, 36(2):369–375 *  non-adherence behaviors and diabetes outcomes, 36(1):15–24 *  patient confidence in screening mammography, 36(6):942–951 *  periodontitis among US adults with multimorbidity, 36(2):313–324 *  physician continuity and cost of care, 36(6):976–985 * **Cultural diversity,** FDA initiative for diversity in clinical trials, 36(2):366–368 * **Culturally sensitive research** *  delays in COVID-19-related hospitalization, 36(5):832–838 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Culture change,** increasing primary care physicians in top leadership roles, 36(4):687–689 * **Data set,** landscape of pregnancy care in community health centers, 36(4):574–582 * **Decision-making,** clinical decision support and medication prescribing, 36(5):777–788 * **Delivery of health care** *  high-quality care requires worthwhile work, 36(1):193–199 *  home health workers' interactions for heart failure, 36(2):369–375 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 * **Delphi method,** standards for dermoscopy education in primary care, 36(1):25–38 * **Demography,** demographics and engagement in interprofessional collaboration, 36(1):88–94 * **Denosumab,** versus bisphosphonates, for reducing fractures, 36(1):175–185 * **Depression** *  antidepressant tapering routine, 36(1):145–151 *  perinatal, detection and management in primary care, 36(6):1071–1086 * **Dermoscopy,** education, standards for, in primary care, 36(1):25–38 * **Diabetes mellitus** *  adherence to diabetes medications during COVID-19, 36(2):289–302 *  non-adherence behaviors and diabetes outcomes, 36(1):15–24 * **Diagnostic imaging,** women at high risk for breast cancer, 36(6):1029–1032 * **Dietary supplements,** infant and maternal vitamin D supplementation, 36(1):95–104 * **Disability,** hearing loss with hospitalization, 36(3):439–448 * **Disease management** *  ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 *  adherence to diabetes medications during COVID-19, 36(2):289–302 *  clinical model of suffering, 36(2):344–355 *  goal-oriented prevention, 36(2):333–338 *  home-based primary care for older adults with limited mobility, 36(4):550–556 *  use of cancer survivorship guidelines, 36(5):789–802 *  utilization of MAT for opioid use disorder, 36(2):251–266 * **Disinformation,** reflections in family medicine, 36(4):692–694 * **Diversity** *  diversifying federal family medicine, 36(1):200–202 *  physician racial diversity in federal sites, 36(1):188–189 * **DNA,** colorectal cancer stool-DNA testing, 36(6):933–941 * **Drug costs,** pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 * **Drug prescriptions,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Drug tapering,** antidepressant tapering routine, 36(1):145–151 * **Dry powder inhalers,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Early detection of cancer** *  low-value prostate cancer screening in primary care, 36(1):152–159 *  lung cancer screening among mammography patients, 36(4):557–564 *  severe harm due to screening colonoscopy, 36(3):493–500 * **Early medical intervention,** virtual Medicare Annual Wellness Visit intervention, 36(3):501–509 * **Editorial Office News and Notes** *  Introducing the Inaugural ABFM Research and Editing Fellow, 36(4):530 *  Peer Reviewers for the Journal of the American Board of Family Medicine in 2022, 36(3):386–389 * **Editors' Notes** *  Family Physicians Can/Should Do: What? Where? And How?, 36(1):1–3 *  Lingering Impact of COVID-19, Preventive Care Considerations, and US Health System Challenges, 36(6):879–882 *  Practicing Family Medicine in a Pandemic World: Lessons for Telemedicine, Health Care Delivery, and Mental Health Care, 36(5):709–711 *  Research Addressing the Ongoing Changes in the Practice of Family Medicine, 36(3):383–385 *  Research Representing the Changing Landscape of Family Medicine, 36(2):207–209 *  Thinking and Practicing Thoughtfully and Thoroughly, 36(4):527–529 * **Elderly,** Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064 * **Electronic cigarettes,** integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Electronic health records** *  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 *  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042 *  COVID-19 and community health center care delivery, 36(6):916–926 *  data challenges for rural colorectal cancer screening, 36(1):118–129 *  determining patients' social needs in, 36(3):510–512 *  integrating a vaping assessment tool into, 36(3):405–413 * **Empathy,** clinical model of suffering, 36(2):344–355 * **End of life care,** clinical model of suffering, 36(2):344–355 * **Entrustable professional services,** implementing competency-based ABFM board eligibility, 36(4):703–707 * **Environmental medicine,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Epidemiology** *  children's special health care needs during COVID-19, 36(5):731–738 *  patient's characteristics and management of symptom diagnoses, 36(3):477–492 * **Equity** *  diversifying federal family medicine, 36(1):200–202 *  physician racial diversity in federal sites, 36(1):188–189 * **Ethnic and racial minorities,** race and ethnicity differences in solo practices, 36(2):380–381 * **Evidence-based medicine,** role of practical wisdom in primary care, 36(4):531–536 * **Exercise** *  failure to participate in sports, 36(6):1033–1037 *  tool to enhance functional status assessment, 36(1):4–14 * **Expert opinion,** standards for dermoscopy education in primary care, 36(1):25–38 * **Family health history,** women at high risk for breast cancer, 36(6):1029–1032 * **Family leave,** ACGME's new family and medical leave policy, 36(1):190–192 * **Family medicine** *  academic detailing, panel management, and colorectal cancer stool-DNA testing, 36(6):933–941 *  ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 *  AI applications in primary care, 36(2):210–220 *  appointment cancellations and hospital utilization, 36(2):339–343 *  clinical model of suffering, 36(2):344–355 *  core values of, and abortion provision, 36(4):583–590 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  departments, advanced practice providers in, 36(6):1058–1061 *  end of the “X-waiver” program, 36(5):867–872 *  family physician early-career compensation, 36(5):851–863 *  federal, diversifying, 36(1):200–202 *  high pain catastrophizing and opioid-related awareness, 36(2):267–276 *  IBH adaptations during COVID-19, 36(6):1023–1028 *  IBH implementation and training in primary care, 36(6):1008–1019 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 *  increasing treatment rates for hepatitis C, 36(4):591–602 *  landscape of pregnancy care in community health centers, 36(4):574–582 *  medical-legal partnership randomized clinical trials, 36(3):414–424 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  patient's characteristics and management of symptom diagnoses, 36(3):477–492 *  physician racial diversity in federal sites, 36(1):188–189 *  practice type and scope of care, 36(1):79–87 *  providers and staff perceptions of AI, 36(2):221–228 *  reducing carbon footprint when prescribing inhalers, 36(2):356–359 *  weight loss management in primary care, 36(1):51–65 * **Family physicians** *  advanced practice providers in family medicine departments, 36(6):1058–1061 *  attending deliveries and providing perinatal care, 36(4):685–686 *  decline in provision of obstetric care, 36(4):690–691 *  determining patients' social needs in EHRs, 36(3):510–512 *  diversifying federal family medicine, 36(1):200–202 *  early-career compensation, 36(5):851–863 *  impact of COVID-19 on, 36(6):905–915 *  providing cesarean sections, 36(4):565–573 *  race and ethnicity differences in solo practices, 36(2):380–381 *  racial diversity in federal sites, 36(1):188–189 * **Focus groups** *  increasing treatment rates for hepatitis C, 36(4):591–602 *  standards for dermoscopy education in primary care, 36(1):25–38 * **Follow-up care,** experiences with lung cancer screening implementation, 36(6):952–965 * **Follow-up studies** *  burnout and commitment after COVID-19, 36(1):105–117 *  telephonic follow-up and risk of COVID-19 death, 36(1):164–169 * **Food assistance,** food insecurity screening in safety-net clinics, 36(2):240–250 * **Food insecurity,** screening, in safety-net clinics, 36(2):240–250 * **Fraud,** access, and future of telemedicine, 36(5):864–866 * **Friendship,** reflections in family medicine, 36(6):1020–1022 * **Functional performance,** tool to enhance functional status assessment, 36(1):4–14 * **Gender differences,** demographics and engagement in interprofessional collaboration, 36(1):88–94 * **Gender equity,** family physician early-career compensation, 36(5):851–863 * **General practitioners,** standards for dermoscopy education in primary care, 36(1):25–38 * **Genetic testing,** guidelines for germline testing of colorectal cancer, 36(2):360–365 * **Geriatrics** *  deployment of digital advance care planning platform, 36(6):966–975 *  health insurance and chronic health conditions, 36(5):839–850 *  home-based primary care for older adults with limited mobility, 36(4):550–556 *  low-value prostate cancer screening in primary care, 36(1):152–159 *  peripheral neuropathy and reduced life expectancy, 36(3):431–438 *  tool to enhance functional status assessment, 36(1):4–14 *  virtual Medicare Annual Wellness Visit intervention, 36(3):501–509 * **Germline mutation,** guidelines for germline testing of colorectal cancer, 36(2):360–365 * **Global warming,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Government regulation and oversight,** pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 * **Graduate medical education,** ACGME's new family and medical leave policy, 36(1):190–192 * **Greenhouse gases,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Harm reduction,** integrating harm reduction into medical care, 36(3):449–461 * **HCV antibodies,** increasing treatment rates for hepatitis C, 36(4):591–602 * **Health behavior,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Health care disparities** *  childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042 *  community health center social risk screening initiatives, 36(5):817–831 *  continuity of care and hospitalization, 36(2):303–312 *  COVID-19 and community health center care delivery, 36(6):916–926 *  FDA initiative for diversity in clinical trials, 36(2):366–368 *  health insurance and chronic health conditions, 36(5):839–850 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Health care economics,** health care costs following COVID-19 hospitalization, 36(6):883–891 * **Health care financing** *  Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064 *  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 * **Health care seeking strategies of patients,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Health care surveys,** obesity and patient-physician relationship, 36(2):325–332 * **Health communication,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Health equity** *  clinical decision support and medication prescribing, 36(5):777–788 *  community health center social risk screening initiatives, 36(5):817–831 *  deployment of digital advance care planning platform, 36(6):966–975 *  quality of care for Latinx children with asthma, 36(4):616–625 *  telehealth and policy implications for equity, 36(5):746–754 * **Health expenditures** *  health care costs following COVID-19 hospitalization, 36(6):883–891 *  home-based primary care for older adults with limited mobility, 36(4):550–556 * **Health-harming legal needs,** medical-legal partnership randomized clinical trials, 36(3):414–424 * **Health information technology,** social isolation and a resource referral platform, 36(5):803–816 * **Health insurance** *  and chronic health conditions, 36(5):839–850 *  Medicare Advantage, 36(6):1062–1064 *  pharmacy benefit managers, 36(6):1065–1067 * **Health literacy** *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  what patients call their inhalers, 36(4):650–661 * **Health personnel,** high-quality care requires worthwhile work, 36(1):193–199 * **Health policy** *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  financial incentives and COVID-19 vaccination, 36(1):170–174 *  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 *  physician perspectives on medical cannabis, 36(4):670–681 *  telehealth and policy implications for equity, 36(5):746–754 * **Health promotion** *  goal-oriented prevention, 36(2):333–338 *  lung cancer screening among mammography patients, 36(4):557–564 *  tool to enhance functional status assessment, 36(1):4–14 * **Health services** *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 * **Health services accessibility** *  attending deliveries and providing perinatal care, 36(4):685–686 *  COVID-19, and community health center care delivery, 36(6):916–926 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  delays in COVID-19-related hospitalization, 36(5):832–838 *  FQHC telemedicine care redesign, 36(5):712–722 *  fraud, access, and future of telemedicine, 36(5):864–866 *  health insurance and chronic health conditions, 36(5):839–850 *  landscape of pregnancy care in community health centers, 36(4):574–582 *  race and ethnicity differences in solo practices, 36(2):380–381 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Hearing loss,** with hospitalization, 36(3):439–448 * **Heart failure,** home health workers' interactions, 36(2):369–375 * **Hepatitis C,** increasing treatment rates for, 36(4):591–602 * **Hispanics** *  delays in COVID-19-related hospitalization, 36(5):832–838 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Hoax,** reflections in family medicine, 36(4):692–694 * **Home care services,** home-based primary care for older adults with limited mobility, 36(4):550–556 * **Home health care,** home health workers' interactions for heart failure, 36(2):369–375 * **Homebound persons,** home-based primary care for older adults with limited mobility, 36(4):550–556 * **Homelessness,** reflections in family medicine, 36(6):1020–1022 * **Hospitalists,** ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 * **Hospitalization** *  COVID-19, health care costs following, 36(6):883–891 *  COVID-19-related, delays in, 36(5):832–838 *  hearing loss with, 36(3):439–448 * **Hospitals** *  increasing primary care physicians in top leadership roles, 36(4):687–689 *  primary care leadership in top ranked US hospitals, 36(4):682–684 * **Humanities,** an exploration of professionalism in practice, 36(3):515–519 * **Hypertension,** ACE inhibitor-induced angioedema of the small bowel, 36(1):160–163 * **ICAN Discussion Aid,** and patient burdens, 36(2):277–288 * **Immunization,** adult MMR boosters and seroconversion, 36(1):142–144 * **Immunocompromised patients,** COVID-19 mRNA vaccination trends, 36(6):927–932 * **Implementation science** *  acceptance of social needs navigation, 36(2):229–239 *  community health center social risk screening initiatives, 36(5):817–831 *  FQHC telemedicine care redesign, 36(5):712–722 *  social screening within US health care settings, 36(4):626–649 * **Inclusiveness** *  diversifying federal family medicine, 36(1):200–202 *  physician racial diversity in federal sites, 36(1):188–189 * **Income,** family physician early-career compensation, 36(5):851–863 * **Infectious diseases,** use of patient-reporting system for predicting influenza, 36(5):766–776 * **Influenza,** predicting, use of patient-reporting system for, 36(5):766–776 * **Informatics,** providers and staff perceptions of AI, 36(2):221–228 * **Inhalers** *  reducing carbon footprint when prescribing, 36(2):356–359 *  what patients call, 36(4):650–661 * **Integrated behavioral health (IBH)** *  adaptations during COVID-19, 36(6):1023–1028 *  implementation and training in primary care, 36(6):1008–1019 * **Integrated delivery systems,** IBH implementation and training in primary care, 36(6):1008–1019 * **Integrated health care systems,** IBH adaptations during COVID-19, 36(6):1023–1028 * **Integrative medicine** *  implementing whole person primary care, 36(4):542–549 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Interdisciplinary health team,** demographics and engagement in interprofessional collaboration, 36(1):88–94 * **Interpersonal psychotherapy,** detection and management of perinatal depression, 36(6):1071–1086 * **Intimate partner violence,** and telemedicine usage, 36(5):755–765 * ***Journal of the American Board of Family Medicine (JABFM)*** *  it’s time to retire the term “provider” from JABFM’s pages, 36(3):520–521 *  peer reviewers for, 36(3):386–389 * **Judgment,** role of practical wisdom in primary care, 36(4):531–536 * **Knowledge translation,** role of practical wisdom in primary care, 36(4):531–536 * **Lactation,** detection and management of perinatal depression, 36(6):1071–1086 * **Language concordance,** quality of care for Latinx children with asthma, 36(4):616–625 * **Latinx** *  delays in COVID-19-related hospitalization, 36(5):832–838 *  quality of care for Latinx children with asthma, 36(4):616–625 * **Leadership** *  an exploration of professionalism in practice, 36(3):515–519 *  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 *  high-quality care requires worthwhile work, 36(1):193–199 *  increasing primary care physicians in top leadership roles, 36(4):687–689 *  in top ranked US hospitals, 36(4):682–684 * **Life expectancy,** reduced, and peripheral neuropathy, 36(3):431–438 * **Lifestyle,** goal-oriented prevention, 36(2):333–338 * **Linear regression** *  demographics and engagement in interprofessional collaboration, 36(1):88–94 *  weight loss management in primary care, 36(1):51–65 * **Logistic models** *  low-value prostate cancer screening in primary care, 36(1):152–159 *  telephonic follow-up and risk of COVID-19 death, 36(1):164–169 * **Logistic regression** *  acceptance of social needs navigation, 36(2):229–239 *  children's special health care needs during COVID-19, 36(5):731–738 *  continuity of care and hospitalization, 36(2):303–312 *  family physicians providing cesarean sections, 36(4):565–573 *  high pain catastrophizing and opioid-related awareness, 36(2):267–276 *  periodontitis among US adults with multimorbidity, 36(2):313–324 *  urine drug testing in patients prescribed opioid therapy, 36(4):537–541 *  use of cancer survivorship guidelines, 36(5):789–802 * **Loneliness** *  intimate partner violence and telemedicine usage, 36(5):755–765 *  reflections in family medicine, 36(6):1020–1022 *  social isolation and a resource referral platform, 36(5):803–816 * **Long-term adverse effects,** severe harm due to screening colonoscopy, 36(3):493–500 * **Longitudinal studies** *  COVID-19 and community health center care delivery, 36(6):916–926 *  intimate partner violence and telemedicine usage, 36(5):755–765 * **Low back pain,** acute, initial care for, 36(6):986–995 * **Lung cancer,** screening *  among mammography patients, 36(4):557–564 *  implementation, experiences with, 36(6):952–965 * **Lung injury,** integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Mammography** *  patients, lung cancer screening among, 36(4):557–564 *  screening, patient confidence in, 36(6):942–951 *  women at high risk for breast cancer, 36(6):1029–1032 * **Maryland,** integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Mass screening,** acceptance of social needs navigation, 36(2):229–239 * **Massachusetts,** delays in COVID-19-related hospitalization, 36(5):832–838 * **Maternal health services** *  attending deliveries and providing perinatal care, 36(4):685–686 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  family physicians providing cesarean sections, 36(4):565–573 * **Measles-mumps-rubella (MMR) vaccine,** adult MMR boosters and seroconversion, 36(1):142–144 * **Medicaid** *  continuity of care and hospitalization, 36(2):303–312 *  expansion, COVID-19, and practice ownership, 36(6):892–904 * **Medical assistants,** high-quality care requires worthwhile work, 36(1):193–199 * **Medical decision-making,** urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **Medical education** *  implementing competency-based ABFM board eligibility, 36(4):703–707 *  physician perspectives on medical cannabis, 36(4):670–681 * **Medical ethics,** clinical model of suffering, 36(2):344–355 * **Medical information,** clinical decision support and medication prescribing, 36(5):777–788 * **Medical marijuana** *  physician perspectives on, 36(4):670–681 *  use for pain versus use for other reasons, 36(6):996–1007 * **Medically underserved areas** *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Medically uninsured** *  health insurance and chronic health conditions, 36(5):839–850 *  telehealth and policy implications for equity, 36(5):746–754 * **Medicare** *  health insurance and chronic health conditions, 36(5):839–850 *  Medicare Advantage, growth amidst mounting scrutiny, 36(6):1062–1064 *  physician continuity and cost of care, 36(6):976–985 *  virtual Medicare Annual Wellness Visit intervention, 36(3):501–509 * **Medicare Advantage,** growth amidst mounting scrutiny, 36(6):1062–1064 * **Medication-assisted treatment (MAT),** utilization of MAT for opioid use disorder, 36(2):251–266 * **Melanoma,** standards for dermoscopy education in primary care, 36(1):25–38 * **Men's health,** low-value prostate cancer screening in primary care, 36(1):152–159 * **Mental health** *  antidepressant tapering routine, 36(1):145–151 *  burnout and commitment after COVID-19, 36(1):105–117 *  children's special health care needs during COVID-19, 36(5):731–738 *  delays in COVID-19-related hospitalization, 36(5):832–838 *  IBH adaptations during COVID-19, 36(6):1023–1028 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  medical-legal partnership randomized clinical trials, 36(3):414–424 *  parental ACEs and child weight, 36(1):39–50 * **Meta-analysis,** denosumab versus bisphosphonates for reducing fractures, 36(1):175–185 * **Metabolic equivalent,** tool to enhance functional status assessment, 36(1):4–14 * **Metered dose inhalers,** carbon footprint, 36(2):356–359 * **Michigan,** hearing loss with hospitalization, 36(3):439–448 * **Minnesota,** parental ACEs and child weight, 36(1):39–50 * **Minority health** *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Monetary incentives,** and COVID-19 vaccination, 36(1):170–174 * **Morbidity,** patient's characteristics and management of symptom diagnoses, 36(3):477–492 * **Motivation,** high pain catastrophizing and opioid-related awareness, 36(2):267–276 * **Multidisciplinary care team,** home-based primary care for older adults with limited mobility, 36(4):550–556 * **Multimorbidity** *  health insurance and chronic health conditions, 36(5):839–850 *  periodontitis among US adults with, 36(2):313–324 * **Musculoskeletal diseases,** outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 * **Musculoskeletal pain,** initial care for acute low back pain, 36(6):986–995 * **Music therapy,** virtual, for substance use disorders, 36(6):1043–1049 * **Narcotics,** utilization of MAT for opioid use disorder, 36(2):251–266 * **National Ambulatory Medical Care Survey (NAMCS)** *  low-value prostate cancer screening in primary care, 36(1):152–159 *  obesity and the patient-physician relationship, 36(2):325–332 * **Natural language processing (NLP),** capture of social needs through, 36(3):513–514 * **New York** *  home health workers' interactions for heart failure, 36(2):369–375 *  integrating harm reduction into medical care, 36(3):449–461 * **Newborns** *  attending deliveries and providing perinatal care, 36(4):685–686 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  landscape of pregnancy care in community health centers, 36(4):574–582 * **Nicotine,** integrating a vaping assessment tool into the EHR, 36(3):405–413 * **Norflurane,** reducing carbon footprint when prescribing inhalers, 36(2):356–359 * **Nurses,** standing orders for buprenorphine follow-up care, 36(5):723–730 * **Nutrition surveys** *  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476 *  periodontitis among US adults with multimorbidity, 36(2):313–324 * **Obesity** *  models for delivering weight management, 36(4):603–615 *  and patient-physician relationship, 36(2):325–332 * **Obstetrics** *  family physicians providing cesarean sections, 36(4):565–573 *  landscape of pregnancy care in community health centers, 36(4):574–582 * **Occupational burnout** *  after COVID-19, 36(1):105–117 *  impact of COVID-19 on family physicians, 36(6):905–915 * **Ohio,** financial incentives and COVID-19 vaccination, 36(1):170–174 * **Opiate substitution treatment,** integrating harm reduction into medical care, 36(3):449–461 * **Opioid-related disorders** *  end of the “X-waiver” program, 36(5):867–872 *  integrating harm reduction into medical care, 36(3):449–461 *  nurse standing orders for buprenorphine follow-up care, 36(5):723–730 *  utilization of MAT for, 36(2):251–266 * **Opioids** *  end of the “X-waiver” program, 36(5):867–872 *  high pain catastrophizing and opioid-related awareness, 36(2):267–276 *  nurse standing orders for buprenorphine follow-up care, 36(5):723–730 *  urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **Oregon** *  acceptance of social needs navigation, 36(2):229–239 *  data challenges for rural colorectal cancer screening, 36(1):118–129 *  experiences with lung cancer screening implementation, 36(6):952–965 * **Organizational innovation** *  implementing whole person primary care, 36(4):542–549 *  models for delivering weight management, 36(4):603–615 * **Orthopedics,** outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 * **Osteoporosis,** denosumab versus bisphosphonates for reducing fractures, 36(1):175–185 * **Osteoporotic fractures,** reducing, denosumab versus bisphosphonates, 36(1):175–185 * **Outcomes assessment** *  non-adherence behaviors and diabetes outcomes, 36(1):15–24 *  quality of care for Latinx children with asthma, 36(4):616–625 *  what patients call their inhalers, 36(4):650–661 * **Outcomes research,** home health workers' interactions for heart failure, 36(2):369–375 * **Outpatients,** virtual music therapy for substance use disorders, 36(6):1043–1049 * **Pain,** high pain catastrophizing and opioid-related awareness, 36(2):267–276 * **Palliative care,** clinical model of suffering, 36(2):344–355 * **Pandemics** *  ACGME's new family and medical leave policy, 36(1):190–192 *  adherence to diabetes medications during COVID-19, 36(2):289–302 *  burnout and commitment after COVID-19, 36(1):105–117 *  children's special health care needs during COVID-19, 36(5):731–738 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  COVID-19 and community health center care delivery, 36(6):916–926 *  FQHC telemedicine care redesign, 36(5):712–722 *  fraud, access, and future of telemedicine, 36(5):864–866 *  health care costs following COVID-19 hospitalization, 36(6):883–891 *  IBH adaptations during COVID-19, 36(6):1023–1028 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  impact of COVID-19 on family physicians, 36(6):905–915 *  intimate partner violence and telemedicine usage, 36(5):755–765 *  telehealth and policy implications for equity, 36(5):746–754 * **Parenting,** parental ACEs and child weight, 36(1):39–50 * **Patient adherence,** lung cancer screening among mammography patients, 36(4):557–564 * **Patient care team** *  an exploration of professionalism in practice, 36(3):515–519 *  continuity, payment, and terms in Canadian health, 36(1):130–141 *  demographics and engagement in interprofessional collaboration, 36(1):88–94 *  IBH implementation and training in primary care, 36(6):1008–1019 *  nurse standing orders for buprenorphine follow-up care, 36(5):723–730 * **Patient-centered care** *  clinical model of suffering, 36(2):344–355 *  community health center social risk screening initiatives, 36(5):817–831 *  goal-oriented prevention, 36(2):333–338 *  ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Patient-centered medical home,** pharmacist e-consult in primary care, 36(3):425–430 * **Patient confidence,** in screening mammography, 36(6):942–951 * **Patient education,** high pain catastrophizing and opioid-related awareness, 36(2):267–276 * **Patient harm,** severe harm due to screening colonoscopy, 36(3):493–500 * **Patient-oriented research,** non-prescription antibiotic use among Hispanic patients, 36(3):390–404 * **Patient readmission** *  appointment cancellations and hospital utilization, 36(2):339–343 *  hearing loss with hospitalization, 36(3):439–448 * **Pediatrics,** childhood wheeze and asthma diagnosis documentation, 36(6):1038–1042 * **Pennsylvania,** physician perspectives on medical cannabis, 36(4):670–681 * **Periodontitis,** among US adults with multimorbidity, 36(2):313–324 * **Peripheral nervous system,** diseases, and reduced life expectancy, 36(3):431–438 * **Peripheral neuropathies,** and reduced life expectancy, 36(3):431–438 * **Person-centered care,** implementing whole person primary care, 36(4):542–549 * **Personal satisfaction,** intimate partner violence and telemedicine usage, 36(5):755–765 * **Personnel relations,** attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 * **Pharmacists** *  e-consult in primary care, 36(3):425–430 *  increasing treatment rates for hepatitis C, 36(4):591–602 * **Pharmacy benefit managers,** growing scrutiny of, 36(6):1065–1067 * **Physician-patient relations** *  and obesity, 36(2):325–332 *  reflections in family medicine, 36(6):1020–1022 *  urine drug testing in patients prescribed opioid therapy, 36(4):537–541 *  what patients call their inhalers, 36(4):650–661 * **Physicians** *  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 *  end of the “X-waiver” program, 36(5):867–872 *  increasing treatment rates for hepatitis C, 36(4):591–602 *  leadership in top ranked US hospitals, 36(4):682–684 *  low-value prostate cancer screening in primary care, 36(1):152–159 *  physician continuity and cost of care, 36(6):976–985 *  utilization of MAT for opioid use disorder, 36(2):251–266 * **Physician's role,** practical wisdom in primary care, 36(4):531–536 * **Policy** *  ACGME's new family and medical leave policy, 36(1):190–192 *  end of the “X-waiver” program, 36(5):867–872 * **Population health,** community health center social risk screening initiatives, 36(5):817–831 * **Population health management,** data challenges for rural colorectal cancer screening, 36(1):118–129 * **Postmenopause,** denosumab versus bisphosphonates for reducing fractures, 36(1):175–185 * **Postpartum depression,** detection and management of, 36(6):1071–1086 * **Postpartum period** *  attending deliveries and providing perinatal care, 36(4):685–686 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  landscape of pregnancy care in community health centers, 36(4):574–582 * **Practice-based research** *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  IBH implementation and training in primary care, 36(6):1008–1019 * **Practice guidelines,** clinical decision support and medication prescribing, 36(5):777–788 * **Practice management,** practice type and scope of care, 36(1):79–87 * **Pregnancy** *  attending deliveries and providing perinatal care, 36(4):685–686 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  detection and management of perinatal depression, 36(6):1071–1086 *  pregnancy care in community health centers, 36(4):574–582 * **Prenatal care,** in community health centers, 36(4):574–582 * **Preparticipation physical examinations,** and failure to participate in sports, 36(6):1033–1037 * **Prescription drugs,** pharmacy benefit managers, growing scrutiny of, 36(6):1065–1067 * **Prescriptions** *  end of the “X-waiver” program, 36(5):867–872 *  Medicare Advantage: growth amidst mounting scrutiny, 36(6):1062–1064 * **Preventive care** *  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476 *  goal-oriented prevention, 36(2):333–338 * **Preventive health services,** virtual Medicare Annual Wellness Visit intervention, 36(3):501–509 * **Preventive medicine** *  lung cancer screening among mammography patients, 36(4):557–564 *  severe harm due to screening colonoscopy, 36(3):493–500 * **Primary care** *  adherence to diabetes medications during COVID-19, 36(2):289–302 *  antidepressant tapering routine, 36(1):145–151 *  appointment cancellations and hospital utilization, 36(2):339–343 *  burnout and commitment after COVID-19, 36(1):105–117 *  cannabis use for pain versus use for other reasons, 36(6):996–1007 *  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476 *  clinical decision support and medication prescribing, 36(5):777–788 *  clinical model of suffering, 36(2):344–355 *  continuity, payment, and terms in Canadian health, 36(1):130–141 *  continuity of care and hospitalization, 36(2):303–312 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  COVID-19 and community health center care delivery, 36(6):916–926 *  demographics and engagement in interprofessional collaboration, 36(1):88–94 *  experiences with lung cancer screening implementation, 36(6):952–965 *  food insecurity screening in safety-net clinics, 36(2):240–250 *  FQHC telemedicine care redesign, 36(5):712–722 *  goal-oriented prevention, 36(2):333–338 *  guidelines for germline testing of colorectal cancer, 36(2):360–365 *  high-quality care requires worthwhile work, 36(1):193–199 *  home-based primary care for older adults with limited mobility, 36(4):550–556 *  IBH adaptations during COVID-19, 36(6):1023–1028 *  IBH implementation and training in, 36(6):1008–1019 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  impact of COVID-19 on family physicians, 36(6):905–915 *  implementing whole person primary care, 36(4):542–549 *  increasing treatment rates for hepatitis C, 36(4):591–602 *  initial care for acute low back pain, 36(6):986–995 *  integrating harm reduction into medical care, 36(3):449–461 *  low-value prostate cancer screening in, 36(1):152–159 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  obesity and patient-physician relationship, 36(2):325–332 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  peripheral neuropathy and reduced life expectancy, 36(3):431–438 *  pharmacist e-consult in, 36(3):425–430 *  physician continuity and cost of care, 36(6):976–985 *  practice type and scope of care, 36(1):79–87 *  quality of care for Latinx children with asthma, 36(4):616–625 *  role of practical wisdom in, 36(4):531–536 *  standards for dermoscopy education in, 36(1):25–38 *  telehealth and policy implications for equity, 36(5):746–754 *  telephonic follow-up and risk of COVID-19 death, 36(1):164–169 *  use of cancer survivorship guidelines, 36(5):789–802 *  virtual music therapy for substance use disorders, 36(6):1043–1049 *  weight loss management in, 36(1):51–65 * **Primary care physicians** *  leadership in top ranked US hospitals, 36(4):682–684 *  top leadership roles, increasing, 36(4):687–689 * **Professionalism,** an exploration of professionalism in practice, 36(3):515–519 * **Prognosis,** peripheral neuropathy and reduced life expectancy, 36(3):431–438 * **Program evaluation,** nurse standing orders for buprenorphine follow-up care, 36(5):723–730 * **Propensity score,** health care costs following COVID-19 hospitalization, 36(6):883–891 * **Prospective studies** *  hearing loss with hospitalization, 36(3):439–448 *  initial care for acute low back pain, 36(6):986–995 *  patient confidence in screening mammography, 36(6):942–951 *  use of patient-reporting system for predicting influenza, 36(5):766–776 * **Prostate cancer,** low-value prostate cancer screening in primary care, 36(1):152–159 * **Prostate-specific antigen,** low-value prostate cancer screening in primary care, 36(1):152–159 * **Psychiatry** *  antidepressant tapering routine, 36(1):145–151 *  detection and management of perinatal depression, 36(6):1071–1086 * **Psychological burnout** *  ACGME's new family and medical leave policy, 36(1):190–192 *  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 *  impact of COVID-19 on family physicians, 36(6):905–915 * **Psychosocial intervention,** detection and management of perinatal depression, 36(6):1071–1086 * **Public health** *  adult MMR boosters and seroconversion, 36(1):142–144 *  FDA initiative for diversity in clinical trials, 36(2):366–368 *  food insecurity screening in safety-net clinics, 36(2):240–250 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  reflections in family medicine, 36(6):1020–1022 * **Qualitative research** *  AI applications in primary care, 36(2):210–220 *  attrition in a multispecialty ambulatory practice network, 36(6):1050–1057 *  burnout and commitment after COVID-19, 36(1):105–117 *  community health center social risk screening initiatives, 36(5):817–831 *  core values of family medicine and abortion provision, 36(4):583–590 *  delays in COVID-19-related hospitalization, 36(5):832–838 *  financial incentives and COVID-19 vaccination, 36(1):170–174 *  food insecurity screening in safety-net clinics, 36(2):240–250 *  FQHC telemedicine care redesign, 36(5):712–722 *  IBH implementation and training in primary care, 36(6):1008–1019 *  impact of COVID-19 on care coordination patients, 36(4):662–669 *  integrating harm reduction into medical care, 36(3):449–461 *  models for delivering weight management, 36(4):603–615 *  non-prescription antibiotic use among Hispanic patients, 36(3):390–404 *  physician perspectives on medical cannabis, 36(4):670–681 *  providers and staff perceptions of AI, 36(2):221–228 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Quality improvement** *  cardiovascular disease risk reduction of quality improvement initiative, 36(3):462–476 *  clinical decision support and medication prescribing, 36(5):777–788 *  deployment of digital advance care planning platform, 36(6):966–975 *  FQHC telemedicine care redesign, 36(5):712–722 *  increasing treatment rates for hepatitis C, 36(4):591–602 *  physician perspectives on medical cannabis, 36(4):670–681 * **Quality of life** *  clinical model of suffering, 36(2):344–355 *  medical-legal partnership randomized clinical trials, 36(3):414–424 * **Radiography,** outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 * **Referral and consultation** *  experiences with lung cancer screening implementation, 36(6):952–965 *  medical-legal partnership randomized clinical trials, 36(3):414–424 *  pharmacist e-consult in primary care, 36(3):425–430 *  social isolation and a resource referral platform, 36(5):803–816 *  women at high risk for breast cancer, 36(6):1029–1032 * **Remote consultation** *  pharmacist e-consult in primary care, 36(3):425–430 *  telephonic follow-up and risk of COVID-19 death, 36(1):164–169 * **Residency,** IBH implementation and training in primary care, 36(6):1008–1019 * **Respiratory tract diseases,** patient-reporting system for predicting influenza, 36(5):766–776 * **Retrospective studies** *  appointment cancellations and hospital utilization, 36(2):339–343 *  COVID-19 mRNA vaccination trends, 36(6):927–932 *  deployment of digital advance care planning platform, 36(6):966–975 *  health insurance and chronic health conditions, 36(5):839–850 *  hearing loss with hospitalization, 36(3):439–448 *  landscape of pregnancy care in community health centers, 36(4):574–582 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  patient's characteristics and management of symptom diagnoses, 36(3):477–492 *  urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **Rickets,** infant and maternal vitamin D supplementation, 36(1):95–104 * **Risk assessment,** guidelines for germline testing of colorectal cancer, 36(2):360–365 * **Rural health** *  data challenges for colorectal cancer screening, 36(1):118–129 *  multi-component intervention for colorectal cancer screening, 36(6):933–941 *  practice type and scope of care, 36(1):79–87 * **Rural population** *  family physicians providing cesarean sections, 36(4):565–573 *  telehealth and policy implications for equity, 36(5):746–754 * **Safety-net clinics** *  food insecurity screening in, 36(2):240–250 *  FQHC telemedicine care redesign, 36(5):712–722 * **SARS-CoV-2,** telephonic follow-up and risk of COVID-19 death, 36(1):164–169 * **Scope of care,** practice type and, 36(1):79–87 * **Scoping review,** implementation of social screening within US health care settings, 36(4):626–649 * **Screening** *  community health center social risk screening initiatives, 36(5):817–831 *  data challenges for rural colorectal cancer screening, 36(1):118–129 *  experiences with lung cancer screening implementation, 36(6):952–965 *  implementation of social screening within US health care settings, 36(4):626–649 *  lung cancer screening among mammography patients, 36(4):557–564 *  multi-component intervention and colorectal cancer screening, 36(6):933–941 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 *  patient confidence in screening mammography, 36(6):942–951 *  preparticipation sports physicals, 36(6):1033–1037 *  reflections in family medicine, 36(6):1020–1022 *  social isolation and a resource referral platform, 36(5):803–816 *  women at high risk for breast cancer, 36(6):1029–1032 * **Selective serotonin reuptake inhibitors,** detection and management of perinatal depression, 36(6):1071–1086 * **Seroconversion,** adult MMR boosters and seroconversion, 36(1):142–144 * **Shared decision-making,** ICAN Discussion Aid and patient burdens, 36(2):277–288 * **Sick leave,** ACGME's new family and medical leave policy, 36(1):190–192 * **Signs and symptoms,** patient's characteristics and management of symptom diagnoses, 36(3):477–492 * **Skin cancer,** standards for dermoscopy education in primary care, 36(1):25–38 * **Small intestine,** ACE inhibitor-induced angioedema of, 36(1):160–163 * **Social care,** patient and patient caregiver perspectives on social screening, 36(1):66–78 * **Social determinants of health** *  acceptance of social needs navigation, 36(2):229–239 *  capture of social needs through NLP, 36(3):513–514 *  community health center social risk screening initiatives, 36(5):817–831 *  determining patients' social needs in EHRs, 36(3):510–512 *  FDA initiative for diversity in clinical trials, 36(2):366–368 *  food insecurity screening in safety-net clinics, 36(2):240–250 *  implementation of social screening within US health care settings, 36(4):626–649 *  medical-legal partnership randomized clinical trials, 36(3):414–424 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 *  reflections in family medicine, 36(6):1020–1022 *  social isolation and a resource referral platform, 36(5):803–816 * **Social isolation,** reflections in family medicine, 36(6):1020–1022 * **Social problems,** reflections in family medicine, 36(6):1020–1022 * **Social risk factors** *  implementation of social screening within US health care settings, 36(4):626–649 *  social isolation and a resource referral platform, 36(5):803–816 * **Socioeconomic factors,** patient and patient caregiver perspectives on social screening, 36(1):66–78 * **Solo practice,** race and ethnicity differences in solo practices, 36(2):380–381 * **Southwestern United States,** extra-articular coccidioidomycosis in the knee, 36(2):376–379 * **Special communications** *  An Exploration of Professionalism in Everyday Practice, 36(3):515–519 *  A Comprehensive Clinical Model of Suffering, 36(2):344–355 *  Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”--Reducing Carbon Footprint When Prescribing Inhalers, 36(2):356–359 * **Special health care needs,** children's, during COVID-19, 36(5):731–738 * **Specialty boards,** implementing competency-based ABFM board eligibility, 36(4):703–707 * **Sports medicine** *  extra-articular coccidioidomycosis in the knee, 36(2):376–379 *  failure to participate in sports, 36(6):1033–1037 * **Standards,** role of practical wisdom in primary care, 36(4):531–536 * **Standing orders,** nurse, for buprenorphine follow-up care, 36(5):723–730 * **Structural equation modeling,** parental ACEs and child weight, 36(1):39–50 * **Students** *  failure to participate in sports, 36(6):1033–1037 *  use of patient-reporting system for predicting influenza, 36(5):766–776 * **Substance-abuse testing,** urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **Substance-related disorders** *  an exploration of professionalism in practice, 36(3):515–519 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Substance use disorders,** nurse standing orders for buprenorphine follow-up care, 36(5):723–730 * **Suffering,** clinical model of, 36(2):344–355 * **Surveys and questionnaires** *  advanced practice providers in family medicine departments, 36(6):1058–1061 *  comparing cannabis use for pain to use for other reasons, 36(6):996–1007 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  detection and management of perinatal depression, 36(6):1071–1086 *  determining patients' social needs in EHRs, 36(3):510–512 *  financial incentives and COVID-19 vaccination, 36(1):170–174 *  impact of COVID-19 on family physicians, 36(6):905–915 *  patient confidence in screening mammography, 36(6):942–951 *  tool to enhance functional status assessment, 36(1):4–14 * **Survivorship,** use of cancer survivorship guidelines, 36(5):789–802 * **Sustained virologic response,** increasing treatment rates for hepatitis C, 36(4):591–602 * **Systematic review** *  implementation of social screening within US health care settings, 36(4):626–649 *  patient and patient caregiver perspectives on social screening, 36(1):66–78 *  severe harm due to screening colonoscopy, 36(3):493–500 * **Systems change,** increasing primary care physicians in top leadership roles, 36(4):687–689 * **Telemedicine** *  acceptance of social needs navigation, 36(2):229–239 *  FQHC telemedicine care redesign, 36(5):712–722 *  fraud, access, and future of telemedicine, 36(5):864–866 *  intimate partner violence and telemedicine usage, 36(5):755–765 *  outcomes of in-person and telemedicine musculoskeletal radiographs, 36(5):739–745 *  telehealth and policy implications for equity, 36(5):746–754 *  use of patient-reporting system for predicting influenza, 36(5):766–776 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Telephone,** follow-up, and risk of COVID-19 death, 36(1):164–169 * **Tennessee,** tool to enhance functional status assessment, 36(1):4–14 * **Training,** implementing whole person primary care, 36(4):542–549 * **Treatment adherence,** non-adherence behaviors and diabetes outcomes, 36(1):15–24 * **Triage,** use of patient-reporting system for predicting influenza, 36(5):766–776 * **Uncertainty,** role of practical wisdom in primary care, 36(4):531–536 * **Urgent care,** practice type and scope of care, 36(1):79–87 * **Urine collection,** urine drug testing in patients prescribed opioid therapy, 36(4):537–541 * **U.S. Department of Health and Human Services,** fraud, access, and future of telemedicine, 36(5):864–866 * **U.S. Department of Veterans Affairs** *  diversifying federal family medicine, 36(1):200–202 *  physician racial diversity in federal sites, 36(1):188–189 * **Vaccination** *  adult MMR boosters and seroconversion, 36(1):142–144 *  COVID-19 mRNA vaccination trends, 36(6):927–932 *  health care costs following COVID-19 hospitalization, 36(6):883–891 * **Vaccination hesitancy,** financial incentives and COVID-19 vaccination, 36(1):170–174 * **Values,** core, of family medicine, and abortion provision, 36(4):583–590 * **Vaping,** assessment tool, integrating into the EHR, 36(3):405–413 * **Veterans,** adherence to diabetes medications during COVID-19, 36(2):289–302 * **Veterans Health Administration,** pharmacist e-consult in primary care, 36(3):425–430 * **Virginia** *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  physician continuity and cost of care, 36(6):976–985 * **Virtual systems,** Medicare Annual Wellness Visit intervention, 36(3):501–509 * **Vitamin D,** infant and maternal vitamin D supplementation, 36(1):95–104 * **Vulnerable populations** *  integrating a vaping assessment tool into the EHR, 36(3):405–413 *  landscape of pregnancy care in community health centers, 36(4):574–582 *  virtual music therapy for substance use disorders, 36(6):1043–1049 * **Washington,** cannabis use for pain versus use for other reasons, 36(6):996–1007 * **Weight loss** *  models for delivering weight management, 36(4):603–615 *  weight loss management in primary care, 36(1):51–65 * **Workflow,** experiences with lung cancer screening implementation, 36(6):952–965 * **Workforce** *  advanced practice providers in family medicine departments, 36(6):1058–1061 *  attending deliveries and providing perinatal care, 36(4):685–686 *  burnout and commitment after COVID-19, 36(1):105–117 *  COVID-19, Medicaid expansion, and practice ownership, 36(6):892–904 *  decline in family practitioners performing obstetric care, 36(4):690–691 *  demographics and engagement in interprofessional collaboration, 36(1):88–94 *  diversifying federal family medicine, 36(1):200–202 *  family physician early-career compensation, 36(5):851–863 *  family physicians providing cesarean sections, 36(4):565–573 *  high-quality care requires worthwhile work, 36(1):193–199 *  impact of COVID-19 on family physicians, 36(6):905–915 *  implementing whole person primary care, 36(4):542–549 *  pharmacist e-consult in primary care, 36(3):425–430 *  physician racial diversity in federal sites, 36(1):188–189 *  practice type and scope of care, 36(1):79–87